MicroRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells

Cancer Biology and Therapy

Volumn 14, Issue 7, 2013, Pages 574-586

  Comincini, Sergio ^a   Allavena, Giulia ^a   Palumbo, Silvia ^a   Morini, Martina ^a   Durando, Francesca ^a   Angeletti, Francesca ^a   Pirtoli, Luigi ^b,c   Miracco, Clelia ^b,c  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c ISTITUTO TOSCANO TUMORI   (Italy)

Author keywords

Autophagy; Glioblastoma; MiR 17

Indexed keywords

CELL PROTEIN; MICRORNA; MICRORNA 17; PROTEIN ATG7; RAPAMYCIN; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATG7 GENE; AUTOPHAGOSOME; AUTOPHAGY; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION; GENE SEQUENCE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IONIZING RADIATION; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RADIATION DOSE; RADIOSENSITIVITY; SEQUENCE ALIGNMENT; TUMOR CELL;

AUTOPHAGY; GLIOBLASTOMA; MIR-17;

ANTINEOPLASTIC AGENTS, ALKYLATING; AUTOPHAGY; CELL LINE, TUMOR; DACARBAZINE; GLIOBLASTOMA; HUMANS; MICRORNAS; RADIATION, IONIZING; UBIQUITIN-ACTIVATING ENZYMES;

EID: 84881186369     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.24597     Document Type: Article

References (54)

1. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132: 27-42; PMID:18191218; http://dx.doi.org/10.1016/j.cell.2007.12.018
2. He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 2009; 43: 67-93; PMID:19653858; http://dx.doi.org/10. 1146/annurev-genet-102808-114910
3. Noda T, Ohsumi Y. Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast. J Biol Chem 1998; 273: 3963-6; PMID:9461583; http://dx.doi.org/10.1074/jbc.273.7.3963
4. Weidberg H, Shvets E, Elazar Z. Biogenesis and cargo selectivity of autophagosomes. Annu Rev Biochem 2011; 80: 125-56; PMID:21548784; http://dx.doi.org/10.1146/annurev-biochem-052709-094552
5. Pópulo H, Lopes JM, Soares P. The mTOR signalling pathway in human Cancer. Int J Mol Sci 2012; 13: 1886-918; PMID:22408430; http://dx.doi.org/10. 3390/ijms13021886
6. Mijaljica D, Prescott M, Devenish RJ. The intriguing life of autophagosomes. Int J Mol Sci 2012; 13: 3618-35; PMID:22489171; http://dx.doi.org/10.3390/ijms13033618
7. Dalby KN, Tekedereli I, Lopez-Berestein G, Ozpolat B. Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy 2010; 6: 322-9; PMID:20224296; http://dx.doi.org/10.4161/ auto.6.3.11625
8. Rosenfeldt MT, Ryan KM. The role of autophagy in tumour development and cancer therapy. Expert Rev Mol Med 2009; 11: e36; PMID:19951459; http://dx.doi.org/10.1017/S1462399409001306
9. Palumbo S, Comincini S. Autophagy and ionizing radiation in tumors: the "survive or not survive" dilemma. J Cell Physiol 2013; 228: 1-8; PMID:22585676; http://dx.doi.org/10.1002/jcp.24118
10. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19: 92-105; PMID:18955434; http://dx.doi.org/10.1101/gr.082701.108
11. Ambros V, Bartel B, Bartel DP, Burge CB, Carrington JC, Chen X, et al. A uniform system for microRNA annotation. RNA 2003; 9: 277-9; PMID:12592000; http://dx.doi.org/10.1261/rna.2183803
12. Rossi JJ. Transcriptional activation by small RNA duplexes. Nat Chem Biol 2007; 3: 136-7; PMID:17301798; http://dx.doi.org/10.1038/nchembio0307-136
13. Lee I, Ajay SS, Yook JI, Kim HS, Hong SH, Kim NH, et al. New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites. Genome Res 2009; 19: 1175-83; PMID:19336450; http://dx.doi.org/10.1101/gr. 089367.108
14. Ajay SS, Athey BD, Lee I. Unified translation repression mechanism for microRNAs and upstream AUGs. BMC Genomics 2010; 11: 155; PMID:20205738; http://dx.doi.org/10.1186/1471-2164-11-155
15. Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010; 79: 351-79; PMID:20533884; http://dx.doi.org/10.1146/annurevbiochem- 060308-103103
16. Fu LL, Wen X, Bao JK, Liu B. MicroRNA-modulated autophagic signaling networks in cancer. Int J Biochem Cell Biol 2012; 44: 733-6; PMID:22342941; http://dx.doi.org/10.1016/j.biocel.2012.02.004
17. Xu J, Wang Y, Tan X, Jing H. MicroRNAs in autophagy and their emerging roles in crosstalk with apoptosis. Autophagy 2012; 8: 873-82; PMID:22082964; http://dx.doi.org/10.4161/auto.19629
18. Aguda BD, Kim Y, Piper-Hunter MG, Friedman A, Marsh CB. MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc Natl Acad Sci U S A 2008; 105: 19678-83; PMID:19066217; http://dx.doi.org/10.1073/pnas.0811166106
19. Grillari J, Hackl M, Grillari-Voglauer R. miR-17-92 cluster: ups and downs in cancer and aging. Biogerontology 2010; 11: 501-6; PMID:20437201; http://dx.doi.org/10.1007/s10522-010-9272-9
20. Li Y, Li Y, Zhang H, Chen Y. MicroRNA-mediated positive feedback loop and optimized bistable switch in a cancer network Involving miR-17-92. PLoS One 2011; 6: e26302; PMID:22022595; http://dx.doi.org/10.1371/journal.pone.0026302
21. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, et al. A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828-33; PMID:15944707; http://dx.doi.org/10.1038/nature03552
22. Cloonan N, Brown MK, Steptoe AL, Wani S, Chan WL, Forrest AR, et al. The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition. Genome Biol 2008; 9: R127; PMID:18700987; http://dx.doi.org/10.1186/gb-2008-9-8- r127
23. Fontana L, Fiori ME, Albini S, Cifaldi L, Giovinazzi S, Forloni M, et al. Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One 2008; 3: e2236; PMID:18493594; http://dx.doi.org/10.1371/ journal.pone.0002236
24. Luo H, Zou J, Dong Z, Zeng Q, Wu D, Liu L. Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma. Biochem J 2012; 442: 311-21; PMID:22132820; http://dx.doi.org/10.1042/BJ20111517
25. Hossain A, Kuo MT, Saunders GF. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol 2006; 26: 8191-201; PMID:16940181; http://dx.doi.org/10.1128/MCB.00242-06
26. Yu Z, Wang C, Wang M, Li Z, Casimiro MC, Liu M, et al. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol 2008; 182: 509-17; PMID:18695042; http://dx.doi.org/10.1083/jcb.200801079
27. Lefranc F, Facchini V, Kiss R. Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist 2007; 12: 1395-403; PMID:18165616; http://dx.doi.org/10.1634/ theoncologist.12-12-1395
28. Kögel D, Fulda S, Mittelbronn M. Therapeutic exploitation of apoptosis and autophagy for glioblastoma. Anticancer Agents Med Chem 2010; 10: 438-49; PMID:20879985; http://dx.doi.org/10.2174/1871520611009060438
29. Lefranc F, Rynkowski M, DeWitte O, Kiss R. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment. Adv Tech Stand Neurosurg 2009; 34: 3-35; PMID:19368079; http://dx.doi.org/10.1007/978-3-211- 78741-0-1
30. Dweep H, Sticht C, Pandey P, Gretz N. miRWalk- -database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform 2011; 44: 839-47; PMID:21605702; http://dx.doi.org/10.1016/j. jbi.2011.05.002
31. Srinivasan S, Patric IR, Somasundaram K. A tenmicroRNA expression signature predicts survival in glioblastoma. PLoS One 2011; 6: e17438; PMID:21483847; http://dx.doi.org/10.1371/journal. pone.0017438
32. Betel D, Koppal A, Agius P, Sander C, Leslie C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 2010; 182: 509-17; PMID:20799968.
33. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8: 445-544; PMID:22966490; http://dx.doi.org/10.4161/auto.19496
34. Palumbo S, Pirtoli L, Tini P, Cevenini G, Calderaro F, Toscano M, et al. Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and temozolomide combined treatments. J Cell Biochem 2012; 113: 2308-18; PMID:22345070; http://dx.doi.org/10.1002/jcb.24102
35. Fassina L, Magenes G, Inzaghi A, Palumbo S, Allavena G, Miracco C, et al. AUTOCOUNTER, an ImageJ JavaScript to analyze LC3B-GFP expression dynamics in autophagy-induced astrocytoma cells. Eur J Histochem 2012; 56: e44; PMID:23361240; http://dx.doi.org/10.4081/ejh.2012.e44
36. Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ 2004; 11: 448-57; PMID:14713959; http://dx.doi.org/10.1038/sj.cdd. 4401359
37. Chen Y, Liersch R, Detmar M. The miR-290-295 cluster suppresses autophagic cell death of melanoma cells. Sci Rep 2012; 2: 808; PMID:23150779; http://dx.doi.org/10.1038/srep00808
38. Chang Y, Yan W, He X, Zhang L, Li C, Huang H, et al. miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. Gastroenterology 2012; 143: 177-87, e8; PMID:22504094; http://dx.doi.org/10.1053/j.gastro. 2012.04.009
39. Kovaleva V, Mora R, Park YJ, Plass C, Chiramel AI, Bartenschlager R, et al. miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells. Cancer Res 2012; 72: 1763-72; PMID:22350415; http://dx.doi.org/10.1158/0008-5472.CAN-11-3671
40. Zhai H, Song B, Xu X, Zhu W, Ju J. Inhibition of autophagy and tumor growth in colon cancer by miR- 502. Oncogene 2013; 32: 1570-9; PMID:22580605; http://dx.doi.org/10.1038/onc.2012.167
41. Zou Z, Wu L, Ding H, Wang Y, Zhang Y, Chen X, et al. MicroRNA-30a sensitizes tumor cells to cisplatinum via suppressing beclin 1-mediated autophagy. J Biol Chem 2012; 287: 4148-56; PMID:22157765; http://dx.doi.org/10. 1074/jbc.M111.307405
42. Frankel LB, Wen J, Lees M, Høyer-Hansen M, Farkas T, Krogh A, et al. microRNA-101 is a potent inhibitor of autophagy. EMBO J 2011; 30: 4628-41; PMID:21915098; http://dx.doi.org/10.1038/emboj.2011.331
43. Zhu H, Wu H, Liu X, Li B, Chen Y, Ren X, et al. Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells. Autophagy 2009; 5: 816-23; PMID:19535919
44. Gabriely G, Yi M, Narayan RS, Niers JM, Wurdinger T, Imitola J, et al. Human glioma growth is controlled by microRNA-10b. Cancer Res 2011; 71: 3563-72; PMID:21471404; http://dx.doi.org/10.1158/0008-5472.CAN-10-3568
45. Gwak HS, Kim TH, Jo GH, Kim YJ, Kwak HJ, Kim JH, et al. Silencing of microRNA-21 confers radiosensitivity through inhibition of the PI3K/AKT pathway and enhancing autophagy in malignant glioma cell lines. PLoS One 2012; 7: e47449; PMID:23077620; http://dx.doi.org/10.1371/journal.pone.0047449
46. Tanzer A, Stadler PF. Molecular evolution of a microRNA cluster. J Mol Biol 2004; 339: 327-35; PMID:15136036; http://dx.doi.org/10.1016/j. jmb.2004.03.065
47. Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S, et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 2004; 64: 3087-95; PMID:15126345; http://dx.doi.org/10.1158/0008-5472.CAN-03-3773
48. Olive V, Jiang I, He L. mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol 2010; 42: 1348-54; PMID:20227518; http://dx.doi.org/10.1016/j.biocel.2010.03.004
49. Komatsu M, Waguri S, Ueno T, Iwata J, Murata S, Tanida I, et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol 2005; 169: 425-34; PMID:15866887; http://dx.doi.org/10.1083/ jcb.200412022
50. Perry J, Okamoto M, Guiou M, Shirai K, Errett A, Chakravarti A. Novel therapies in glioblastoma. Neurol Res Int 2012; 2012: 428565; PMID:22530121; http://dx.doi.org/10.1155/2012/428565
51. Torres S, Lorente M, Rodríguez-Fornés F, Hernández- Tiedra S, Salazar M, García-Taboada E, et al. A combined preclinical therapy of cannabinoids and temozolomide against glioma. Mol Cancer Ther 2011; 10: 90-103; PMID:21220494; http://dx.doi.org/10.1158/1535-7163.MCT-10-0688
52. Zhuang D, Liu Y, Mao Y, Gao L, Zhang H, Luan S, et al. TMZ-induced PrPc/par-4 interaction promotes the survival of human glioma cells. Int J Cancer 2012; 130: 309-18; PMID:21328340; http://dx.doi.org/10.1002/ijc.25985
53. Zhuang W, Qin Z, Liang Z. The role of autophagy in sensitizing malignant glioma cells to radiation therapy. Acta Biochim Biophys Sin (Shanghai) 2009; 41: 341-51; PMID:19430698; http://dx.doi.org/10.1093/abbs/gmp028
54. Barbieri G, Palumbo S, Gabrusiewicz K, Azzalin A, Marchesi N, Spedito A, et al. Silencing of cellular prion protein (PrPC) expression by DNA-antisense oligonucleotides induces autophagy-dependent cell death in glioma cells. Autophagy 2011; 7: 840-53; PMID:21478678; http://dx.doi.org/10.4161/auto.7.8. 15615